Factor Va - factor Xa interactions: molecular sites involved in enzyme:cofactor assembly

REFERENCES

• Davie EW, Fujikawa K, Kisiel W. The coagula-tion cascade: initiation, maintenance, and regula-tion. Biochemistry 1991; 30; 10363–70.
   Google Scholar
• Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 1990; 76; 1–16.
   Google Scholar
• Kane WH, Davie EW. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and throm-botic disorders. Blood 1988; 71; 539–55.
   PubMedGoogle Scholar
• Jenny RJ, Tracy PB, Mann KG. The physiology and biochemistry of factor V. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and thrombosis, 3rd ed. Edinburgh: Churchill Livingstone; 1994. p. 456–76
   Google Scholar
• Nesheim ME, Taswell JB, Mann KG. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem 1979; 254; 10952–62.
   Google Scholar
• van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor Villa in the activation of bovine factor X. J Biol Chem 1981; 256; 3433–42.
   PubMed Web of Science ®Google Scholar
• Dahlback B. Blood coagulation. Lancet 2000; 355; 1627–32.
   PubMed Web of Science ®Google Scholar
• Kalafatis M, Rand MD, Mann KG. The mechan-ism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269; 31869–80.
   Google Scholar
• Harlos K, Martin DM, O'Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EG, Boys CW. Crystal structure of the extra-cellular region of human tissue factor. Nature 1994; 370; 662–6.
   Google Scholar
• Bode W, Brandstetter H, Mather T, Stubbs MT. Comparative analysis of haemostatic proteinases: structural aspects of thrombin, factor Xa, factor IXa and protein C. Thromb Haemost 1997; 78; 501–11.
   PubMedGoogle Scholar
• Banner DW, D'Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380; 41–6.
   PubMed Web of Science ®Google Scholar
• Villoutreix BO, Dahlback B. Structural investiga-tion of the A domains of human blood coagula-tion factor V by molecular modeling. Protein Sci 1998; 7; 1317–25.
   PubMedGoogle Scholar
• Pellequer JL, Gale AJ, Getzoff ED, Griffin JH. Three-dimensional model of coagulation factor Va bound to activated protein C. Thromb Haemost 2000; 84; 849–57.
   PubMedGoogle Scholar
• Monkovic DD, Tracy PB. Activation of human factor V by factor Xa and thrombin. Biochemistry 1990; 29; 1118–28.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Dahlback B, Stenflo J. Thrombin-catalyzed activation of human coagulation factor V. J Biol Chem 1982; 257; 6556–64.
   Google Scholar
• DiScipio RG, Hermadson MA, Yates SG, Davic DE. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor) and Protein S. Biochemistry 1977; 14; 698–706.
   Google Scholar
• Steinberg M, Nemerson Y. Hemostasis and thrombosis. Philadelphia: Lippincott 1987.
   Google Scholar
• McMullen BA, Fujikawa K, Kisiel W, Sasagawa T, Howald WN, Kwa EY, Weinstein B. Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identifi-cation of residue 63 as beta- hydroxyaspartic acid. Biochemistry 1983; 22; 2875–84.
   Google Scholar
• Mertens K, Cupers R, Van Wijngaarden A, Bertina RM. Binding of human blood-coagulation Factors IXa and X to phospholipid membranes. Biochem J 1984; 223; 599–605.
   PubMedGoogle Scholar
• Bloom JW, Nesheim ME, Mann KG. Phospholipid-binding properties of bovine factor V and factor Va. Biochemistry 1979; 18; 4419–25.
   Google Scholar
• van de Waart P, Bruls H, Hemker HC, Lindhout T. Interaction of bovine blood clotting factor Va and its subunits with phospholipid vesicles. Biochemistry 1983; 22; 2427–32.
   PubMedGoogle Scholar
• Pusey ML, Nelsestuen GL. Membrane binding properties of blood coagulation Factor V and derived peptides. Biochemistry 1984; 23; 6202–10.
   PubMedGoogle Scholar
• Lindhout T, Govers-Riemslag JW, van de Waart P, Hemker HC, Rosing J. Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition. Biochemistry 1982; 21; 5494–502.
   Google Scholar
• Ortel TL, Quinn-Allen MA, Keller FG, Peterson JA, Larocca D, Kane WH. Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras. J Biol Chem 1994; 269; 15898–905.
   PubMedGoogle Scholar
• Ortel TL. Clinical and laboratory manifestations of anti-factor V antibodies. J Lab Clin Med 1999; 133; 326–34.
   PubMed Web of Science ®Google Scholar
• Nicolaes GA, Villoutreix BO, Dahlback B. Muta-tions in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex. Blood Coagul Fibrinolysis 2000; 11; 89–100.
   Google Scholar
• Bakker HM, Tans G, Thomassen MC, Yukelson LY, Ebberink R, Hemker HC, Rosing J. Func-tional properties of human factor Va lacking the Asp683-Arg70 9 domain of the heavy chain. J Biol Chem 1994; 269; 20662–7.
   Google Scholar
• Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP, Rosing J. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270; 21158–66.
   PubMed Web of Science ®Google Scholar
• Camire RM, Kalafatis M, Tracy PB. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg154 5 optimizes cofactor function by facilitating factor Xa binding. Biochemistry 1998; 37; 11896–906.
   Google Scholar
• Deguchi H, Takeya H, Gabazza EC, Nishioka J, Suzuki K. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrom-binase complex. Biochem J 1997; 321; 729–35.
   Google Scholar
• Boscovic DS, Giles AR, Nesheim ME. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phos-pholipid. J Biol Chem 1990; 265; 10497–505.
   Google Scholar
• Kotkow KJ, Deitcher SR, Furie B, Furie BC. The second kringle domain of prothrombin promotes factor Va-mediated prothrombin activation by prothrombinase. J Biol Chem 1995; 270; 4551–7.
   PubMedGoogle Scholar
• Luckow EA, Lyons DA, Ridgeway TM, Esmon CT, Laue TM. Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction: analysis by analytical ultracentrifuga-tion. Biochemistry 1989; 28; 2348–54.
   Google Scholar
• McDonald JF, Shah AM, Schwalbe RA, Kisiel W, Dahlback B, Nelsestuen GL. Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and mem-brane binding properties suggests a membrane contact site. Biochemistry 1997; 36; 5120–7.
   PubMedGoogle Scholar
• Lu Y, Nelsestuen GL. Dynamic features of prothrombin interaction with phospholipid vesi-cles of different size and composition: implications for protein—membrane contact. Biochemistry 1996; 35; 8193–200.
   PubMedGoogle Scholar
• Mertens K, Celie PH, Kolkman JA, Lenting PJ. Factor VIII—factor IX interactions: molecular sites involved in enzyme-cofactor complex assem-bly. Thromb Haemost 1999; 82; 209–17.
   PubMedGoogle Scholar
• Rudolph AE, Porche-Sorbet R, Miletich JP. Definition of a factor Va binding site in factor Xa. J Biol Chem 2001; 276; 5123–8.
   PubMedGoogle Scholar
• Steen M, Dahlback B. Thrombin-mediated pro-teolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site. J Biol Chem 2002; 277; 38424–30.
   PubMedGoogle Scholar